Ascentage Pharma Grp International (6855): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 31,38 Hongkong Dollar | 79,3 Hongkong Dollar | 30 Hongkong Dollar |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 71,914 Hongkong Dollar | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 373.555.768 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 559.261,137 | 980.650 | 221.984 | 209.711 | 27.910 | 12.450 | 14.513 | 6.807 | 6.328 | 7.667 |
Cashflow aus operativer Geschäftstätigkeit | -1.174.128 | -111.357 | -726.077 | -653.915 | -604.679 | -609.956 | -460.305 | -237.667 | -107.985 | -45.893 |
▸ Operative Cashflow Marge | -209,94% | -11,36% | -327,09% | -311,82% | -2.166,53% | -4.899,24% | -3.171,67% | -3.491,51% | -1.706,46% | -598,58% |
Investitionsausgaben (CapEx) | 27.571 | 24.289 | 56.844 | 203.288 | 435.415 | 249.921 | 77.456 | 49.460 | 20.536 | 3.371 |
Cashflow aus Investitionstätigkeit | -1.000.052 | -362.035 | 21.922 | -384.612 | -466.522 | -107.367 | -201.333 | 292.808 | -230.347 | -152.611 |
Cashflow aus Finanzierungstätigkeit | 2.540.100 | 314.767 | 368.751 | 619.268 | 1.781.387 | 1.040.003 | 442.362 | 860.163 | 58.362 | 435.535 |
Freier Cashflow | -1.201.699 | -135.646 | -782.921 | -857.203 | -1.040.094 | -859.877 | -537.761 | -287.127 | -128.521 | -49.264 |
▸ Freie Cashflow Marge | -214,87% | -13,83% | -352,69% | -408,75% | -3.726,6% | -6.906,64% | -3.705,37% | -4.218,11% | -2.030,99% | -642,55% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -9.036 | 533.946 | -5.923 | -26.776 | -25.874 | 634.217 | 432.279 | 835.024 | 60.893 | 436.116 |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.